本页面由Tiger Trade Technology Pte. Ltd.提供服务

德康医疗

85.92
+1.812.15%
盘后:86.190.2700+0.31%19:45 EDT
成交量:299.21万
成交额:2.56亿
市值:324.23亿
市盈率:33.88
高:86.10
开:84.60
低:84.21
收:84.11
52周最高:92.59
52周最低:54.11
股本:3.77亿
流通股本:3.76亿
量比:0.92
换手率:0.80%
股息:- -
股息率:- -
每股收益(TTM):2.54
每股收益(LYR):2.09
净资产收益率:38.49%
总资产收益率:10.33%
市净率:12.37
市盈率(LYR):41.12

数据加载中...

2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/24

重要事件披露

Form 8-K - Current report
2024/10/24

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/25

重要事件披露

Form 8-K - Current report
2024/07/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities